Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 12/20 | 0.67 |
| ▸ | KMT2A | Q03164 | 11/20 | 0.67 |
| ▸ | KDM4E | B2RXH2 | 10/20 | 0.67 |
| ▸ | MEN1 | O00255 | 9/20 | 0.67 |
| ▸ | USP2 | O75604 | 6/20 | 0.67 |
| ▸ | MAPT | P10636 | 6/20 | 0.67 |
| ▸ | GAA | P10253 | 6/20 | 0.67 |
| ▸ | LMNA | P02545 | 5/20 | 0.67 |
| ▸ | HSD17B10 | Q99714 | 5/20 | 0.67 |
| ▸ | HPGD | P15428 | 4/20 | 0.67 |
| ▸ | CASP1 | P29466 | 4/20 | 0.67 |
| ▸ | CASP7 | P55210 | 4/20 | 0.67 |
| ▸ | GLA | P06280 | 2/20 | 0.67 |
| ▸ | ATM | Q13315 | 2/20 | 0.67 |
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.67 |
| ▸ | TDP1 | Q9NUW8 | 3/20 | 0.63 |
| ▸ | HTT | P42858 | 2/20 | 0.63 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.63 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.63 |
| ▸ | GPR35 | Q9HC97 | 1/20 | 0.63 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL903151 | 0.89 | ALDH1A1 (0.68) | ALDH1A1KMT2AKDM4EMEN1USP2 | |
| SCHEMBL1213320 | 0.88 | KMT2A (0.63) | ALDH1A1KMT2AKDM4EMEN1USP2 | |
| SCHEMBL12892379 | 0.88 | ALDH1A1 (0.63) | ALDH1A1KMT2AKDM4EMEN1USP2 | |
| SCHEMBL1212238 | 0.88 | ALDH1A1 (0.63) | ALDH1A1KMT2AKDM4EMEN1USP2 | |
| SCHEMBL14303297 | 0.88 | ALDH1A1 (0.63) | ALDH1A1KMT2AKDM4EMEN1USP2 | |
| SCHEMBL24623305 | 0.85 | ALDH1A1 (0.64) | ALDH1A1KMT2AKDM4EMEN1USP2 | |
| SCHEMBL3202594 | 0.85 | KMT2A (0.61) | ALDH1A1KMT2AKDM4EMEN1USP2 | |
| SCHEMBL14303302 | 0.85 | KMT2A (0.67) | ALDH1A1KMT2AKDM4EMEN1USP2 | |
| Hydrochloric Acid SCHEMBL31718750 | 0.84 | KMT2A (0.60) | ALDH1A1KMT2AKDM4EMEN1USP2 | |
| SCHEMBL13486811 | 0.82 | KMT2A (0.57) | ALDH1A1KMT2AKDM4EMEN1USP2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 143 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20160334393-A1 | Use of Novel Coumarins as Glutathione and Thiol Labels | Life Technologies Corporation | 2016-11-17 | — | — | US | claimed |
| US-8981100-B2 | Use of novel coumarins as glutathione and thiol labels | Life Technologies Corporation (US) | 2015-03-17 | — | — | US | claimed |
| US-20110045503-A1 | The Use of Novel Coumarins as Glutathione and Thiol Labels | Life Technologies Corporation (US) | 2011-02-24 | — | — | US | claimed |
| US-12637489-B2 | Silicon containing modified nucleotide analogs | Singular Genomics Systems, Inc. (US) | 2026-05-26 | — | — | US | disclosed |
| US-12630808-B2 | Modified archaeal family b polymerases | Singular Genomics Systems, Inc. (US) | 2026-05-19 | — | — | US | disclosed |
| US-20260125660-A1 | MODIFIED ARCHAEAL FAMILY B POLYMERASES | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-05-07 | — | — | US | disclosed |
| US-20260110028-A1 | NUCLEOTIDE ANALOGS AND USES THEREOF | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-04-23 | — | — | US | disclosed |
| US-12595508-B2 | Nucleotide cleavable linkers and uses thereof | Singular Genomics Systems, Inc. (US) | 2026-04-07 | — | — | US | disclosed |
| US-20260085299-A1 | ENGINEERED PYROCOCCUS ENZYMES AND USES THEREOF | SINGULAR GENOMICS SYSTEMS INC (US) | 2026-03-26 | — | — | US | disclosed |
| EP-4713368-A1 | ANTI-CD28 ANTIBODIES AND METHODS RELATED THERETO | Adimab, LLC (US) | 2026-03-25 | — | — | EP | disclosed |
| US-12577271-B2 | Modified nucleotides and uses thereof | Singular Genomics Systems, Inc. (US) | 2026-03-17 | — | — | US | disclosed |
| US-8981100-B2 | Use of novel coumarins as glutathione and thiol labels | Life Technologies Corporation (US) | 2015-03-17 | — | — | US | disclosed |
| US-8981100-B2 | Use of novel coumarins as glutathione and thiol labels | Life Technologies Corporation (US) | 2015-03-17 | — | — | US | disclosed |
| US-20150064703-A1 | RAPID ANTIBIOTIC SUSCEPTIBILITY TESTING | PRESIDENT AND FELLOWS OF HARVARD COLLEGE | 2015-03-05 | — | — | US | disclosed |
| EP-2820147-A1 | RAPID ANTIBIOTIC SUSCEPTIBILITY TESTING | President and Fellows of Harvard College (US) | 2015-01-07 | — | — | EP | disclosed |
| WO-2013130875-A1 | RAPID ANTIBIOTIC SUSCEPTIBILITY TESTING | PRESIDENT AND FELLOWS OF HARVARD COLLEGE (US) | 2013-09-06 | — | — | WO | disclosed |
| US-20110045503-A1 | The Use of Novel Coumarins as Glutathione and Thiol Labels | Life Technologies Corporation (US) | 2011-02-24 | — | — | US | disclosed |
| US-20110045503-A1 | The Use of Novel Coumarins as Glutathione and Thiol Labels | Life Technologies Corporation (US) | 2011-02-24 | — | — | US | disclosed |
| US-20110045503-A1 | The Use of Novel Coumarins as Glutathione and Thiol Labels | Life Technologies Corporation (US) | 2011-02-24 | — | — | US | disclosed |
| WO-2009018112-A2 | THE USE OF NOVEL COUMARINS AS GLUTATHIONE AND THIOL LABELS | INVITROGEN CORPORATION (US) | 2009-02-05 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (9 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-12630808-B2 | Modified archaeal family b polymerases | SSU72, POLB, POLQ | ALDH1A1 2884/4885KMT2A 308/4885KDM4E 1080/4885 |
| US-12595508-B2 | Nucleotide cleavable linkers and uses thereof | NSUN2, CCRL2, NOP2 | ALDH1A1 3274/4885KMT2A 2804/4885KDM4E 4144/4885 |
| US-12577271-B2 | Modified nucleotides and uses thereof | NUDT1, NSUN2, CCRL2 | ALDH1A1 2320/4885KMT2A 2809/4885KDM4E 4569/4885 |
| US-12637489-B2 | Silicon containing modified nucleotide analogs | NSUN2, POLR2H, POLH | ALDH1A1 3879/4885KMT2A 2375/4885KDM4E 4429/4885 |
| US-20260110028-A1 | NUCLEOTIDE ANALOGS AND USES THEREOF | POLL, POLB, POLN | ALDH1A1 2325/4885KMT2A 1209/4885KDM4E 2493/4885 |
| US-20260085299-A1 | ENGINEERED PYROCOCCUS ENZYMES AND USES THEREOF | POLB, POLM, POLRMT | ALDH1A1 4563/4885KMT2A 1696/4885KDM4E 1438/4885 |
| US-20160334393-A1 | Use of Novel Coumarins as Glutathione and Thiol Labels | GSTP1, GSTK1, GSTA1 | ALDH1A1 341/4885KMT2A 4686/4885KDM4E 4664/4885 |
| US-20110045503-A1 | The Use of Novel Coumarins as Glutathione and Thiol Labels | GSTP1, GSTK1, GSTA1 | ALDH1A1 365/4885KMT2A 4601/4885KDM4E 4635/4885 |
| US-20260125660-A1 | MODIFIED ARCHAEAL FAMILY B POLYMERASES | DNMT3A, POLB, POLM | ALDH1A1 3860/4885KMT2A 755/4885KDM4E 995/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.